Employer
German Cancer Research Center, Heidelberg, Germany
Description
Therapeutic monoclonal antibodies (mAbs) and CAR T cell-based immunotherapies are revolutionizing the treatment landscape in MM. Examples include, but are not limited to, monoclonal antibodies targeting CD38, bispecific antibodies targeting GPRC5D × CD3, and BCMA × CD3. Despite being in clinical use, the molecular binding mechanisms of antibodies and the target antigens remain elusive. The prospective doctoral candidate will be trained and is expected to design and implement advanced fluorescence imaging experimental workflows (SMLM and/or lightsheet and/or expansion microscopy) with the aim of discerning the intricate spatial organization of BCMA and GPRC5D antigens on MM cell membranes when treated with traditional and bispecific mAbs, with the final aim of understanding mechanisms of antigen escape in MM treatment.
Please mention Life Science Network when applying
Share
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 42
- Comments 0
Recommended
Post a comment
Comments
More jobs
-
Research Associate (Limited Term) University of Toronto
-
PhD position - Mitochondrial membrane protein structure and function Julich Research Centre
-
PhD student (f,m,div) in Plant Biology Institute for Vegetable and Ornamental Crops
-
PhD Student in Mutagenic Chemotherapy Driving Treatment Resistance German Cancer Research Center
